查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1212516

基於DNA 探針的診斷藥的全球市場

DNA Probes-Based Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

基於DNA 探針的診斷藥的全球市場2030年將達到311億美元

在COVID-19後改變的商務環境中的使用了2022年149億美元的DNA探針診斷藥的全球市場在2030年前將修正達到311億美元的規模，在分析期間2022-2030年間將以9.6％的年複合成長率增長。本報告所分析的市場區隔之一的感染疾病將記錄年複合成長率9.5％，到分析期間結束時將達到184億美元。考慮疫情後的復甦，癌症領域今後8年的年複合成長率將修正為10.5％。

美國市場估算為44億美元，中國預測將以年複合成長率9％的速度成長。

使用了美國的DNA探針的診斷藥市場，2022年成為44億美元。作為世界第2大經濟大國的中國，在2022年到2030年間以年複合成長率9％推移在2030年前將修正達到54億美元的市場規模。其他熱門的地區市場有日本和加拿大，從2022年到2030各將以8.5％和8.1％的速度成長。在歐洲市場中，德國以年複合成長率7.5％成長。

調查對像企業範例

  • Abbott Molecular
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • bioMerieux
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Life Sciences
  • Luminex Corporation
  • QIAGEN N.V.
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP-3405

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global DNA Probes-Based Diagnostics Market to Reach $31.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for DNA Probes-Based Diagnostics estimated at US$14.9 Billion in the year 2022, is projected to reach a revised size of US$31.1 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2022-2030. Infectious Diseases, one of the segments analyzed in the report, is projected to record a 9.5% CAGR and reach US$18.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cancer segment is readjusted to a revised 10.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.4 Billion, While China is Forecast to Grow at 9% CAGR

The DNA Probes-Based Diagnostics market in the U.S. is estimated at US$4.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 8.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Select Competitors (Total 46 Featured):

  • Abbott Molecular
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • bioMerieux
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Life Sciences
  • Luminex Corporation
  • QIAGEN N.V.
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • What are DNA-Probes?
    • Recent Market Activity
    • DNA-based Diagnostics - A Prelude
    • DNA Tests: Finding Use in Numerous Applications
    • DNA Probes: Robust Growth Ahead
    • Developed Markets: Traditional Revenue Contributors
    • The United States: Unraveling the Country's Edge in DNA-based Diagnostics
    • Infectious Diseases Tests Dominate the DNA-based Diagnostics Market
    • Developing Countries Excel in Growth Prospects
    • Decoding the Genetic Puzzle
    • Growth Drivers in a Nutshell
    • Growth Inhibitors in a Nutshell
    • Genetic Profiling of Pathogens: A Road Less Traveled
    • Roche's Entry into the Hall of Molecular Fame
    • DNA Technology: An Evolutionary Scan
    • Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005
    • Market Opportunities
    • DNA Probes-Based Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
    • Abbott Molecular (USA)
    • Beckman Coulter, Inc. (USA)
    • Becton, Dickinson and Company (USA)
    • bioMerieux (France)
    • F. Hoffmann-La Roche Ltd. (Switzerland)
    • GE Healthcare Life Sciences (UK)
    • Luminex Corporation (USA)
    • QIAGEN N.V. (Netherlands)
    • Siemens Healthineers (Germany)
    • Thermo Fisher Scientific, Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • World's Aging Population Drives the Popularity of DNA-Probe Tests
    • Global Aging Population Statistics - Opportunity Indicators
    • Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics
    • AIDS: A Global Epidemic
    • Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth
    • Reimbursements: "Under the Umbrella"
    • Evolution of New & Virulent Infectious Agents
    • Challenges in Widespread Deployment of DNA-based Diagnostics
    • DNA Probe Technology Gains Prominence in Diagnosing Vaginitis
    • Gene Banks - A Ray of Hope for the Future
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Genetic Predisposition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Identity / Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Identity / Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Identity / Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 19: World DNA Probes-Based Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 22: USA 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 25: Canada 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • JAPAN
    • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 28: Japan 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • CHINA
    • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: China Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: China 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • EUROPE
    • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: Europe 18-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: Europe 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • FRANCE
    • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: France Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: France 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • GERMANY
    • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Germany 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: Italy 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: UK 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: Rest of Europe 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: Asia-Pacific 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 56: Rest of World Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Rest of World Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: Rest of World 18-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2012, 2023 & 2030

IV. COMPETITION